Mechanism of Action of Natural Compounds in Peripheral Multiorgan Dysfunction and Hippocampal Neuroinflammation Induced by Sepsis.

Coriolus versicolor cecal ligation and perforation inflammation neurodegenerative disorders pathway

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
03 Mar 2023
Historique:
received: 03 02 2023
revised: 28 02 2023
accepted: 01 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Bacterial sepsis induces the production of excessive pro-inflammatory cytokines and oxidative stress, resulting in tissue injury and hyperinflammation. Patients recovering from sepsis have increased rates of central nervous system (CNS) morbidities, which are linked to long-term cognitive impairment, such as neurodegenerative pathologies. This paper focuses on the tissue injury and hyperinflammation observed in the acute phase of sepsis and on the development of long-term neuroinflammation associated with septicemia. Here we evaluate the effects of Coriolus versicolor administration as a novel approach to treat polymicrobial sepsis. Rats underwent cecal ligation and perforation (CLP), and Coriolus versicolor (200 mg/kg in saline) was administered daily by gavage. Survival was monitored, and tissues from vital organs that easily succumb to infection were harvested after 72 h to evaluate the histological changes. Twenty-eight days after CLP, behavioral analyses were performed, and serum and brain (hippocampus) samples were harvested at four weeks from surgery. Coriolus versicolor increased survival and reduced acute tissue injury. Indeed, it reduced the release of pro-inflammatory cytokines in the bloodstream, leading to a reduced chronic inflammation. In the hippocampus, Coriolus versicolor administration restored tight junction expressions, reduce cytokines accumulation and glia activation. It also reduced toll-like receptor 4 (TLR4) and neuronal nitric oxide synthase (nNOS) and the NLR family pyrin domain containing 3 (NLRP3) inflammasome components expression. Coriolus versicolor showed antioxidant activities, restoring glutathione (GSH) levels and catalase and superoxide dismutase (SOD) activities and reducing lipid peroxidation, nitrite and reactive oxygen species (ROS) levels. Importantly, Coriolus versicolor reduced amyloid precursor protein (APP), phosphorylated-Tau (p-Tau), pathologically phosphorylated tau (PHF1), phosphorylated tau (Ser202 and Thr205) (AT8), interferon-induced transmembrane protein 3 (IFITM3) expression, and β-amyloid accumulation induced by CLP. Indeed, Coriolus versicolor restored synaptic dysfunction and behavioral alterations. This research shows the effects of Coriolus versicolor administration on the long-term development of neuroinflammation and brain dysfunction induced by sepsis. Overall, our results demonstrated that Coriolus versicolor administration was able to counteract the degenerative process triggered by sepsis.

Identifiants

pubmed: 36978883
pii: antiox12030635
doi: 10.3390/antiox12030635
pmc: PMC10045853
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Front Pharmacol. 2018 Mar 20;9:249
pubmed: 29615912
Foods. 2022 Sep 02;11(17):
pubmed: 36076858
Toxics. 2022 Feb 09;10(2):
pubmed: 35202267
Brain Behav Immun. 2015 Jan;43:54-9
pubmed: 25019583
Nat Rev Neurosci. 2006 Jan;7(1):41-53
pubmed: 16371949
Alzheimers Res Ther. 2015 Mar 24;7(1):33
pubmed: 25802557
Biomedicines. 2022 May 05;10(5):
pubmed: 35625810
Toxics. 2022 Apr 18;10(4):
pubmed: 35448459
Braz J Psychiatry. 2022 May-Jun;44(3):245-247
pubmed: 34730671
JAMA. 2010 Oct 27;304(16):1787-94
pubmed: 20978258
Exp Neurol. 2018 Apr;302:68-74
pubmed: 29291404
PLoS One. 2017 Jun 8;12(6):e0178553
pubmed: 28594885
Vascul Pharmacol. 2002 Jun;38(6):323-37
pubmed: 12529927
Lancet Respir Med. 2015 Jan;3(1):61-9
pubmed: 25434614
Biomark Insights. 2020 Aug 21;15:1177271920950319
pubmed: 32913390
Front Immunol. 2017 Sep 06;8:1087
pubmed: 28932226
CNS Neurol Disord Drug Targets. 2020;19(1):27-43
pubmed: 31914916
Intensive Care Med Exp. 2015 Dec;3(1):30
pubmed: 26515197
Antioxidants (Basel). 2020 Jul 09;9(7):
pubmed: 32660140
Crit Care Med. 2010 May;38(5):1276-83
pubmed: 20308885
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Intensive Care Med. 2003 Oct;29(10):1782-9
pubmed: 12783160
Antioxidants (Basel). 2021 May 14;10(5):
pubmed: 34068924
Cells. 2022 Aug 22;11(16):
pubmed: 36010690
Biomed Pharmacother. 2020 May;125:110023
pubmed: 32092830
J Biol Chem. 2018 Jan 5;293(1):226-244
pubmed: 29127203
Mol Neurobiol. 2018 May;55(5):3642-3659
pubmed: 28523565
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2348-52
pubmed: 19181857
Sci Rep. 2021 Aug 11;11(1):16315
pubmed: 34381131
Oxid Med Cell Longev. 2015;2015:604658
pubmed: 26543520
Neuroscience. 1989;31(3):571-91
pubmed: 2687721
J Neuroinflammation. 2008 Sep 15;5:38
pubmed: 18793399
Neurotoxicology. 2016 Mar;53:350-358
pubmed: 26433056
Int J Mol Sci. 2021 Apr 13;22(8):
pubmed: 33924360
J Neuroinflammation. 2019 Feb 18;16(1):44
pubmed: 30777084
Chem Biol Interact. 2020 Jan 25;316:108927
pubmed: 31843630
Antioxidants (Basel). 2021 Jun 02;10(6):
pubmed: 34199629
Int J Mol Sci. 2020 Oct 18;21(20):
pubmed: 33080989
FASEB J. 2020 Mar;34(3):4085-4106
pubmed: 31950563
J Mol Neurosci. 2019 Jun;68(2):295-303
pubmed: 30955191
J Neuroinflammation. 2015 May 13;12:90
pubmed: 25962427
Front Cell Neurosci. 2017 Aug 31;11:266
pubmed: 28912688
J Gen Virol. 2008 Feb;89(Pt 2):467-473
pubmed: 18198377
Int J Biol Macromol. 2014 Aug;69:12-9
pubmed: 24857871
Antioxidants (Basel). 2021 May 20;10(5):
pubmed: 34065584
Mol Neurobiol. 2013 Aug;48(1):62-70
pubmed: 23479197
Int J Mol Sci. 2020 Oct 20;21(20):
pubmed: 33092214
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:187-194
pubmed: 29169997
Crit Care Med. 2006 Mar;34(3):886-9
pubmed: 16505668
Mol Neurobiol. 2018 Feb;55(2):1045-1053
pubmed: 28092082
Antioxidants (Basel). 2022 Feb 17;11(2):
pubmed: 35204289
J Immunol. 2006 Aug 1;177(3):1967-74
pubmed: 16849510
Shock. 2005 Dec;24 Suppl 1:19-23
pubmed: 16374368
PLoS One. 2017 Feb 7;12(2):e0170346
pubmed: 28170408
Pharm Res. 2008 Aug;25(8):1751-61
pubmed: 18493843
J Alzheimers Dis. 2013;33 Suppl 1:S123-39
pubmed: 22710920
Int J Biol Macromol. 2016 May;86:352-61
pubmed: 26802244
Lancet. 2003 Nov 29;362(9398):1799-805
pubmed: 14654318
Molecules. 2020 Sep 26;25(19):
pubmed: 32993187
Crit Care. 2010;14(4):R140
pubmed: 20667108
Intensive Care Med Exp. 2016 Dec;4(1):22
pubmed: 27430881
Antioxidants (Basel). 2021 Oct 22;10(11):
pubmed: 34829535
Can J Neurol Sci. 2003 May;30(2):98-105
pubmed: 12774948
BMC Vet Res. 2013 Jun 21;9:123
pubmed: 23800279
Crit Care Med. 2016 Aug;44(8):1461-7
pubmed: 26992066
Sci Rep. 2019 Feb 27;9(1):2904
pubmed: 30814582
Shock. 2003 Apr;19(4):310-3
pubmed: 12688540
Curr Opin Crit Care. 2011 Oct;17(5):480-6
pubmed: 21900767
Brain Behav Immun. 2017 Feb;60:1-12
pubmed: 26995317
Crit Care Med. 2005 Jan;33(1):221-3; discussion 262-3
pubmed: 15644673
Lancet Neurol. 2014 Jun;13(6):630-6
pubmed: 24849863
Antioxidants (Basel). 2020 Jul 24;9(8):
pubmed: 32722199

Auteurs

Ramona D'Amico (R)

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres, n 31, 98166 Messina, Italy.

Mario Tomasello (M)

Department of Biomedical and Biotechnological Sciences, University of Catania, 95124 Catania, Italy.

Daniela Impellizzeri (D)

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres, n 31, 98166 Messina, Italy.

Marika Cordaro (M)

Department of Biomedical, Dental and Morphological and Functional Imaging, University of Messina, Via Consolare Valeria, 98125 Messina, Italy.

Rosalba Siracusa (R)

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres, n 31, 98166 Messina, Italy.

Livia Interdonato (L)

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres, n 31, 98166 Messina, Italy.

Ali Saber Abdelhameed (AS)

Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 14451, Saudi Arabia.

Roberta Fusco (R)

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres, n 31, 98166 Messina, Italy.

Vittorio Calabrese (V)

Department of Biomedical and Biotechnological Sciences, University of Catania, 95124 Catania, Italy.

Salvatore Cuzzocrea (S)

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres, n 31, 98166 Messina, Italy.

Rosanna Di Paola (R)

Department of Vererinary Sciences, University of Messina, Viale Annunziata, 98168 Messina, Italy.

Classifications MeSH